Aspira Women's Health Files S-1/A Update
Ticker: AWHL · Form: S-1/A · Filed: 2025-05-06T00:00:00.000Z
Sentiment: neutral
Topics: sec-filing, registration-statement, corporate-update
TL;DR
Aspira Women's Health (AWH) filed an S-1/A. Stay tuned for updates.
AI Summary
Aspira Women's Health Inc. filed an S-1/A on May 6, 2025, to update its registration statement. The company, formerly known as Vermillion, Inc., Ciphergen Biosystems Inc., and Abiotic Systems, is focused on in vitro and in vivo diagnostic substances. Their business address is in Austin, TX.
Why It Matters
This filing indicates Aspira Women's Health Inc. is actively managing its public securities and corporate structure, which is crucial for investor confidence and regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine S-1/A filing for corporate registration updates, not indicating immediate financial distress or significant new risks.
Key Numbers
- 333-286561 — SEC File Number (Identifies the specific registration filing)
- 25915764 — Film Number (Internal SEC processing number)
Key Players & Entities
- Aspira Women's Health Inc. (company) — Filer
- 0000926617 (company) — Central Index Key
- VERMILLION, INC. (company) — Former Company Name
- CIPHERGEN BIOSYSTEMS INC (company) — Former Company Name
- ABIOTIC SYSTEMS (company) — Former Company Name
- 20250506 (date) — Filing Date
FAQ
What is the primary purpose of this S-1/A filing for Aspira Women's Health Inc.?
The filing is an amendment to a registration statement, indicating updates or changes related to the company's securities.
When was this S-1/A filing submitted to the SEC?
The filing was submitted on May 6, 2025.
What industry does Aspira Women's Health Inc. operate in?
The company is in the 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' industry, with SIC code 2835.
Has Aspira Women's Health Inc. operated under different names previously?
Yes, the company was formerly known as VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC, and ABIOTIC SYSTEMS.
Where is Aspira Women's Health Inc. located?
The company's business and mailing address is 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX 78738.
From the Filing
0001641172-25-008770.txt : 20250506 0001641172-25-008770.hdr.sgml : 20250506 20250506100837 ACCESSION NUMBER: 0001641172-25-008770 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 73 FILED AS OF DATE: 20250506 DATE AS OF CHANGE: 20250506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-286561 FILM NUMBER: 25915764 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 S-1/A 1 forms-1a.htm S-1/A true 0000926617 S-1/A http://fasb.org/us-gaap/2024#NonoperatingIncomeExpense http://fasb.org/us-gaap/2024#NonoperatingIncomeExpense 0000926617 2024-01-01 2024-12-31 0000926617 dei:BusinessContactMember 2024-01-01 2024-12-31 0000926617 2024-12-31 0000926617 2023-12-31 0000926617 2023-01-01 2023-12-31 0000926617 us-gaap:ProductMember 2024-01-01 2024-12-31 0000926617 us-gaap:ProductMember 2023-01-01 2023-12-31 0000926617 AWH:GeneticsMember 2024-01-01 2024-12-31 0000926617 AWH:GeneticsMember 2023-01-01 2023-12-31 0000926617 us-gaap:CommonStockMember 2022-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000926617 us-gaap:RetainedEarningsMember 2022-12-31 0000926617 2022-12-31 0000926617 us-gaap:CommonStockMember 2023-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000926617 us-gaap:RetainedEarningsMember 2023-12-31 0000926617 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0000926617 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000926617 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0000926617 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0000926617 us-gaap:CommonStockMember 2024-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000926617 us-gaap:RetainedEarningsMember 2024-12-31 0000926617 AWH:AtTheMarketOfferingAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:AtTheMarketOfferingAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:EquityLineOfCreditAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:EquityLineOfCreditAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:TwoThousandTwentyThreeDirectOfferingMember 2024-01-01 2024-12-31 0000926617 AWH:TwoThousandTwentyThreeDirectOfferingMember 2023-01-01 2023-12-31 0000926617 AWH:TwoThousandTwentyFourDirectOfferingMember 2024-01-01 2024-12-31 0000926617 AWH:TwoThousandTwentyFourDirectOfferingMember 2023-01-01 2023-12-31 0000926617 AWH:WarrantInducementAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:WarrantInducementAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:SecuritiesPurchaseAgreementsMember 2024-01-01 2024-12-31 0000926617 AWH:SecuritiesPurchaseAgreementsMember 2023-01-01 2023-12-31 0000926617 AWH:TwoThousandTwentyFourAtTheMarketOfferingAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:TwoThousandTwentyFourAtTheMarketOfferingAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:PrivatePlacementOfferingMember 2024-01-01 2024-12-31 0000926617 AWH:PrivatePlacementOfferingMember 2023-01-01 2023-12-31 0000926617 2024-07-01 0000926617 2024-10-17 0000926617 us-gaap:SubsequentEventMember 2025-02-11 0000926617 srt:MaximumMember 2024-12-31 0000926617 srt:MinimumMember 2024-12-31 0000926617 srt:Maximum